Ramina Fazeli: Highlighting the Emerging Role of Neutrophil Extracellular Traps in Ovarian Cancer
Ramina Fazeli, Medical Doctor at Alborz University of Medical sciences, shared a post on LinkedIn about a recent article she and her collegues co-authored, published in adding:
“This review highlights the emerging role of neutrophil extracellular traps (NETs) in ovarian cancer progression, tumor microenvironment remodeling, immune evasion, angiogenesis, and therapeutic resistance.
We also discussed the molecular pathways involved in NETosis and explored the potential of NET-targeted therapies as promising strategies to improve treatment response and patient outcomes in ovarian cancer.
I am grateful to all co-authors and collaborators for their valuable contributions to this work.
I hope this article adds to the growing understanding of the complex interactions between inflammation, immunity, and cancer biology.”
Title: The neutrophil–NET Axis in ovarian cancer: Drivers of tumor microenvironment remodeling and therapeutic resistance
Authors: Hoda Zendehdel, Mahsa Esgandari, Paria Panahinia, Ramina Fazeli, Atoosa Etezadi, Sania Rahimi
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 13, 2026, 17:08W. Alberto Sifuentes Giraldo: Urticarial Vasculitis Clinical Features, Systemic Involvement, and Treatment
-
Sep 13, 2026, 16:58Let’s Debunk Some Myths about Blood in SCD – ASCO
-
Sep 13, 2026, 16:56William Wallace: A Magnesium Ion Decides Whether Your Brain Learns or Not
-
Sep 13, 2026, 16:54Meet NBDF’s 2026 Excellence Fellowship Recipients – National Bleeding Disorders Foundation
-
Sep 13, 2026, 16:52Kaloyan Takov: Native Lp(a) Carries a Distinct Triglyceride Signature Linked to Cardiovascular Disease
-
Sep 13, 2026, 16:51Axay Tomar: How Simulation-Based Education Shapes Safer Transfusion Practices
-
Sep 13, 2026, 16:51Edina Cenko: AZURE-HeFH Highlights the LDL-C Treatment Gap in HeFH
-
Sep 13, 2026, 16:49William Aird: Why Is LDH Elevated In Splenic Infarction?
-
Sep 13, 2026, 16:48David McIntosh: PPTA Calls for Action on the Global Shortage of Plasma-Derived Medicines